U.S. market Closed. Opens in 57 minutes

OLMA | Olema Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue377.00K1.66M1.66M11.00K9.03KN/A
Gross Profit-377.00K-1.66M-1.66M-11.00K-9.03KN/A
Operating Expenses104.96M106.99M71.49M21.53M4.32M2.08M
Selling, General & Admin18.82M24.71M20.39M7.82M403.00K386.00K
Research & Development86.14M82.27M51.10M13.70M3.92M1.69M
Other Operating ExpensesN/A-27.00K-47.00KN/AN/A-31.00K
Operating Income-104.96M-106.99M-71.49M-21.53M-4.32M-2.08M
Other Expenses / Income8.31M2.20M395.00K-593.00K7.00K-94.00K
Before Tax Income-96.66M-104.79M-71.10M-22.12M-4.32M-2.20M
Income Tax ExpensesN/A-2.20M-210.00K642.00K-155.86K-90.00K
Net Income-96.66M-102.59M-70.89M-22.76M-4.32M-2.20M
Interest ExpensesN/A-357.00KN/A653.00KN/A28.00K
Basic Shares Outstanding45.25M40.00M39.52M39.31M40.17M14.10M
Diluted Shares Outstanding45.25M40.00M39.52M39.31M40.17M14.10M
EBITDA-104.58M-106.99M-71.10M-21.47M-4.31M-2.07M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-96.66M-105.14M-71.10M-21.47M-4.47M-2.26M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙